COMPOUNDS THAT MODULATE THE ADENOSINE RECEPTOR

AR110763B1Active Publication Date: 2026-08-26ARCUS BIOSCIENCES INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: ARP20180100131
Authority / Receiving Office: AR · AR
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2017-03-30
Filing Date: 2018-01-19
Publication Date: 2026-08-26
Estimated Expiration: 2038-01-19

Application Information

Patent Timeline

30 Mar 2017

Priority

19 Jan 2018

Application

ARP20180100131

26 Aug 2026

Publication

AR110763B1

IPC: C07D401/14; A61P35/00; A61P37/02

Inventors: BEATTY, JOEL; DEBIEN, LAURENT

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

This paper describes a compound that is an inhibitor of at least one of the adenosine A receptors 2A already 2B and compositions containing the compound and methods for synthesizing the compound. The use of such compound and compositions for the treatment of a diverse set of diseases, disorders, and conditions, including cancer-related disorders and immune disorders mediated, at least in part, by the adenosine A receptor 2A , and / or adenosine A receptor 2B .

Need to check novelty before this filing date? Find Prior Art

Claims

1. A compound, characterized in that said compound is selected from the group consisting of: (FORMULAS) or a pharmaceutically acceptable salt thereof. Two further claims follow.